PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩200 per share · Prices as of the 2026-10-02 close
PJ Electronics is an electronics manufacturing service (EMS) provider spanning medical devices, automotive electronics, and robot controllers, with consolidated revenue and operating profit rising for four consecutive years through 2025, extending an earnings recovery trend.
2025 consolidated revenue of KRW 178.5bn and operating profit of KRW 11.0bn, rising every year since 2022
GE and Siemens ultrasound board supply plus Hyundai Mobis-linked automotive electronics orders are the core growth drivers
Its industrial robot controller supply relationship with Hyundai Robotics has drawn renewed market attention as a robotics theme
Owners' net income swung from a loss in 2Q25 to profits from 3Q25 onward, though the profit size narrowed again in 2Q26
Debt ratio has steadily declined from 53.9% in 2022 to 42.1% in 2025, indicating improving financial stability
Founded in 1969 and listed on KOSDAQ in 1993, PJ Electronics is an electronics manufacturing service (EMS) company headquartered and operating factories in Bucheon, Gyeonggi Province, providing total solutions spanning product planning, material sourcing, production, and logistics.
The company has described its business as organized into medical devices, automotive electronics, robot controllers, IT components, and other SMD/SET processing segments.
In the medical device segment, the company supplies ultrasound diagnostic device boards to global manufacturers including GE and Siemens, positioned as a core growth driver. The automotive electronics segment produces electronics parts on order from domestic and overseas firms including Hyundai Mobis.
In the robot controller segment, the company has maintained a supply relationship providing industrial robot controllers, a relationship that has recently drawn renewed market attention amid expectations for robotics industry expansion.
The IT components segment manufactures a range of communication and information device parts including boards for telecom equipment, GPS modules, and set-top boxes.
The company holds multiple quality certifications including ISO 13485 for medical devices, TS16949 for automotive, and QS-9000, positioning itself as an EMS specialist in high-value, high-complexity product manufacturing.
Competitively, it faces domestic small and mid-sized EMS rivals, but its simultaneous presence across medical devices, automotive electronics, and robot controllers stands out as a diversification feature.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩39.7B | ₩1.5B | 3.7% |
| 2025Q3 | ₩45.4B | ₩2.4B | 5.4% |
| 2025Q4 | ₩48.6B | ₩2.8B | 5.7% |
| 2026Q1 | ₩51.1B | ₩1.8B | 3.6% |
| 2026Q2 | ₩50.7B | ₩1.8B | 3.5% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩157.7B | ₩6.1B | ₩7B | 3.9% | 5.8% | 53.9% |
| 2023 | ₩166.8B | ₩7.4B | ₩6.1B | 4.4% | 4.9% | 49.0% |
| 2024 | ₩169.3B | ₩10.8B | ₩9.2B | 6.4% | 6.9% | 44.6% |
| 2025 | ₩178.6B | ₩11B | ₩9.4B | 6.1% | 6.7% | 42.1% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23
In 2025, consolidated revenue reached KRW 178.55 billion, up from KRW 169.30 billion in 2024, while operating profit rose modestly to KRW 10.96 billion from KRW 10.78 billion in 2024.
Operating margin improved in stages from 3.9% in 2022 to 4.4% in 2023, 6.4% in 2024, and 6.1% in 2025, reflecting a gradual profitability recovery in the post-pandemic period.
Owners' net income declined from KRW 6.96 billion in 2022 to KRW 6.11 billion in 2023, before recovering to KRW 9.22 billion in 2024 and KRW 9.35 billion in 2025.
On a quarterly basis, owners' net income posted a loss of KRW -129.5 million in 2Q25, before swinging to profits of KRW 2.46 billion in 3Q25 and expanding further to KRW 3.58 billion in 4Q25.
In 1Q26, revenue hit a quarterly high of KRW 51.09 billion with net income of KRW 3.84 billion, but 2Q26 saw revenue slip slightly to KRW 50.66 billion while operating profit fell to KRW 1.76 billion and net income to KRW 1.84 billion, a notable contraction from the prior quarter.
Operating cash flow, which was only KRW 1.14 billion in 2022 and KRW 3.46 billion in 2023, jumped to KRW 21.15 billion in 2024 and KRW 26.88 billion in 2025, indicating a marked improvement in the cash conversion quality of earnings.
Nonetheless, the 2Q25 loss and the 2Q26 profit contraction show that quarter-to-quarter earnings volatility remains a feature of the business.
As an EMS business, performance is driven by the order cycles of downstream customers, and PJ Electronics is exposed to three distinct end markets: medical devices, automotive electronics, and robot controllers.
In the medical device segment, the new-model release cycle for ultrasound diagnostic equipment and the outsourcing policies of global manufacturers such as GE and Siemens directly affect results.
The automotive electronics segment stands to benefit from deepening vehicle electrification amid the spread of electric and autonomous vehicles.
In the robot controller segment, recent industry attention followed Hyundai Motor Group's Physical AI strategy reveal at CES 2026, where Hyundai Motor Group held a CES 2026 media day themed 'AI Robotics, Beyond the Lab into Life,' unveiling a Physical AI humanoid 'Atlas development model' the size of an adult male (170cm) to the public for the first time.
Amid this backdrop, as speculation emerged that HD Hyundai Robotics could pursue an IPO valued at up to KRW 8 trillion, PJ Electronics, identified as an external partner with a confirmed cooperative relationship in the industrial robot controller field, has been cited as a key beneficiary.
Regarding the robotics semiconductor and components market, Morgan Stanley projected the robotics semiconductor market, including humanoid robots, would grow to roughly USD 305 billion (about KRW 440 trillion) by 2045.
However, the specific revenue contribution or contract size of the robot controller segment for PJ Electronics has not been confirmed through disclosed filings or reliable sources, meaning a gap may still exist between thematic expectations and actual financial contribution.
Competitively, while smaller in scale than large EMS peers, its simultaneous exposure to three growth industries—medical devices, automotive, and robotics—is cited as a differentiating factor.
The company has stated, on a standalone basis, that expanded orders for new GE and Siemens ultrasound diagnostic device models in the medical device segment and increased orders from domestic and overseas firms including Hyundai Mobis in the automotive electronics segment drove earnings improvement.
In the robot controller segment, it has been noted that the company has pursued the fast-growing robot market, including past industrial robot controller supply contracts with Hyundai Robotics, and whether HD Hyundai Robotics proceeds with an IPO—and the associated potential for greater partner revenue contribution—will be a point to watch going forward.
There is also a view that the automotive electronics segment has room to grow amid expanding electric and autonomous vehicle markets, alongside expectations of rising robot controller demand from manufacturing automation and smart factory transitions.
However, the fact that revenue, operating profit, and net income all contracted quarter-on-quarter in 2Q26 after a quarterly record in 1Q26 suggests future results may continue to fluctuate depending on specific customer and model cycles.
Going into the second half of 2026, the continuity of new orders in the medical device segment and order flow in automotive electronics and robot controllers will likely be key points to monitor.
No specific annual guidance or capacity expansion plans from the company have been confirmed through recent disclosures or media reports.
Owners' net income passed through a trough in 2023 before recovering through 2024 and 2025, and the sum of the most recent four quarters (3Q25-2Q26) exceeds the level of full-year results seen in prior years.
The price-to-book ratio trades at a discount to net asset value, while the price-to-earnings ratio moves within the historical trading band this stock has recorded in the past.
The company has a history of paying cash dividends in recent years, though the dividend yield level can vary depending on annual dividend policy and the scale of earnings.
That said, the contraction in earnings scale in 2Q26 relative to the prior quarter could become a variable factor affecting the earnings estimates that underlie valuation metrics going forward.
Given that its market capitalization falls in the small-cap range within KOSDAQ, it is also worth considering that price volatility driven by trading volume or thematic flows can be relatively pronounced.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23
Revenue and operating profit increased every year from 2022 to 2025, with operating margin improving from 3.9% to 6.1%. Owners' net income passed through a 2023 trough before rising again in 2024-2025.
Operating cash flow also grew markedly from about KRW 1.1 billion in 2022 to KRW 26.9 billion in 2025, underpinning the cash-generating capacity of earnings.
The company is simultaneously exposed to disparate end markets—global medical device makers like GE and Siemens, automotive electronics customers such as Hyundai Mobis, and robotics companies including Hyundai Robotics. This structure could allow weakness in orders from one industry to be offset by strength in another.
Exposure to three growth industries—medical devices, automotive, and robotics—is an unusual diversification feature for an EMS company.
The debt ratio has steadily fallen from 53.9% in 2022 to 42.1% in 2025. Total equity also grew every year, from KRW 120.6 billion in 2022 to KRW 139.4 billion in 2025. The financial structure has improved in tandem with the earnings recovery.
Owners' net income posted a loss in 2Q25, and after a quarterly record in 1Q26, revenue, operating profit, and net income all declined quarter-on-quarter in 2Q26. This illustrates that quarterly results can swing significantly depending on the timing of specific customer and model orders.
The industrial robot controller supply relationship with Hyundai Robotics has drawn market attention, but the specific share of total revenue or contract size from this segment has not been confirmed through publicly disclosed data.
There is a possibility that thematic expectations are reflected in the share price first, while the actual financial contribution materializes with a time lag.
With a market capitalization in the small-cap range within KOSDAQ, there have been instances of the share price moving sharply over short periods due to thematic trading flows or volume shifts.
The potential for prices to swing based on supply-demand factors independent of earnings fundamentals is a point of note for small-cap investing.
Revenue may be concentrated among a small number of large customers such as GE, Siemens, Hyundai Mobis, and Hyundai Robotics. Results could be sensitive to changes in major customers' outsourcing policies or model transition timing. The progress of new customer diversification needs ongoing monitoring.
As an EMS company, PJ Electronics is exposed to foreign exchange fluctuations and global supply chain cost changes in sourcing components and raw materials. Rising semiconductor or electronic component prices, or shifts in logistics costs, could affect production costs. This can act as a factor behind quarter-to-quarter swings in operating margin.
There have been instances where the share price moved independently of earnings fundamentals due to thematic news related to robot controllers or reports of a potential HD Hyundai Robotics IPO. If such themes fade or fall short of expectations, price volatility could widen. Investors need to distinguish between thematic news and actual disclosed content when making decisions.
Check whether 3Q26 revenue, operating profit, and net income reverse the contraction seen in 2Q26 or decelerate further.
Monitor whether HD Hyundai Robotics formalizes its IPO plans and timeline, and whether this translates into actual orders or revenue for PJ Electronics' robot controller segment.
Check whether full-year 2026 revenue and operating margin improve versus 2025, and whether the annual report discloses more specific segment-level revenue mix changes.
Check the scale of the fiscal year 2026 year-end dividend and whether the dividend policy continues.
PJ Electronics is an EMS company simultaneously exposed to three disparate end markets—medical devices, automotive electronics, and robot controllers—having extended an earnings recovery with revenue and operating profit rising every year from 2022 through 2025.
The swing to profitability in owners' net income from 3Q25 onward and the sharp increase in operating cash flow point to a qualitative improvement in earnings. However, 2Q26 saw revenue, operating profit, and net income all contract quarter-on-quarter, underscoring that quarterly volatility persists.
The robot controller segment has drawn market attention amid speculation over an HD Hyundai Robotics IPO, but the segment's specific revenue contribution has not been confirmed through publicly disclosed data, meaning a gap could exist between thematic expectations and actual fundamentals.
On the financial structure side, stability appears to be improving, with the debt ratio steadily declining and total equity rising each year.
Going forward, the continuity of new orders in the medical device segment and whether the robot controller segment's promise translates into actual revenue will likely be key points to watch.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.